|
May 28
|
Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
|
|
May 28
|
Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
|
|
May 27
|
Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down
|
|
May 26
|
Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?
|
|
May 23
|
Bristol-Myers Squibb (NYSE:BMY) Showcases Breakthrough Oncology Data at ASCO 2025 Meeting
|
|
May 23
|
EXEL Reports Superior Efficacy Data From Kidney Cancer Study Cohort
|
|
May 23
|
With 81% ownership, Bristol-Myers Squibb Company (NYSE:BMY) boasts of strong institutional backing
|
|
May 22
|
Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
|
|
May 22
|
1 Safe-and-Steady Stock to Own for Decades and 2 to Think Twice About
|
|
May 22
|
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)
|
|
Apr 24
|
Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy.
|
|
Apr 24
|
Bristol Myers Squibb Reverses Its Losing Spree On First-Quarter Beat
|
|
Apr 24
|
Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields.
|
|
Apr 24
|
Bristol-Myers Squibb (NYSE:BMY) Raises 2025 Revenue Guidance Following Strong Q1 Performance
|
|
Apr 24
|
Netflix's new high, Bristol Myers outlook, Texas Instruments pops
|
|
Apr 24
|
Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact
|
|
Apr 24
|
BMY Beats on Q1 Earnings and Sales, Raises 2025 Outlook
|
|
Apr 24
|
Compared to Estimates, Bristol Myers (BMY) Q1 Earnings: A Look at Key Metrics
|
|
Apr 24
|
Drugmakers brace for Trump tariffs, while weighing numerous other worries
|
|
Apr 24
|
Bristol Myers says schizophrenia drug launch ‘off to a solid start’
|